Skip to main content

Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer.

Koh YW, Lee HJ, Lee JW, Kang J, Gong G

Publication: Mod Pathol (2011) • Vol 24 • Page 794-800PMID: 21317877View on PubMed

Purpose

The purpose of this paper was to compare the determination of human epidermal growth factor receptor 2 (HER2) status by single- and dual-color silver-enhanced in situ hybridization (SISH) and fluorescence in situ hybridization (FISH) in invasive breast carcinoma specimens.

Conclusion

High HER2 status concordance rates were demonstrated between dual-color SISH and FISH or single-color SISH.

Studies (1)

Purpose

The purpose of this study was to compare the determination of HER2 status by single- and dual-color SISH and FISH in invasive breast carcinoma specimens. Discrepant cases were also assessed by immunohistochemistry (IHC).

Summary of Findings

High HER2 status concordance rates were demonstrated between dual-color SISH and FISH (141/146 cases, 97%) and dual-color SISH and single-color SISH (142/146 cases, 97%). Of the 7 cases showing any discordance between analytical methods, HER2 status determined by IHC was in concordance with the FISH results in 5 cases.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNAIn situ hybridization
    DNATissue microarray
    DNAFISH
    ProteinImmunohistochemistry
    ProteinTissue microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    In situ hybridization SpecificTechnology platform
    Dual-color SISH
    FISH
    Immunohistochemistry
    Single-color SISH